Context Therapeutics Secures $100 Million in Private Placement to Fuel Clinical Trials
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX), a biopharmaceutical company, announced a private placement agreement expected to generate approximately $100 million in gross proceeds. This influx of capital, before …
Context Therapeutics Secures $100 Million in Private Placement to Fuel Clinical Trials Read More